Current screening approaches for prostate cancer center on the measurement of serum prostate-specific antigen (PSA) in combination with adjuncts such as measurement of molecular forms of PSA, multiparametric MRI, and digital rectal examination2–6. The gene discussed is KLK3; the disease is Familial prostate cancer.